Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Share News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

Thu, 17th Jun 2021 11:43

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Midatech Pharma PLC, up 89% at 51.90 pence, 12-month range 18.10p-87.00p. The biotechnology company says it has data demonstrating that its Q-Sphera technology can formulate monoclonal antibodies into long-acting injectables, a novel development in pharmaceuticals with significant medical and commercial potential. "The company believes no other commercial or academic organisation has been able to successfully deliver therapeutic proteins over extended periods using methods capable of commercial scaling," it says.

----------

Blue Prism Group PLC, up 7.4% at 964.50p, 12-month range 883.50p-1,900.00p. The robotic process automation firm posts narrowed interim loss after seeing growing revenue and booking numbers for the period. Blue Prism reports a pretax loss of GBP21.0 million for the six months ended April 30, sharply narrowed from GBP53.8 million a year prior. Bookings grew 35% in the first half to GBP98 million, or 39% at constant currency. Revenue for the period increased by 21% year-on-year to GBP80.4 million from GBP66.6 million, with recurring, subscription-based, licence revenue accounting for a 98% share.

----------

AIM - LOSERS

----------

Open Orphan PLC, down 14% at 30.00p, 12-month range 11.16p-34.50p. The pharmaceutical services company posts 2020 pretax loss GBP11.2 million, widened from GBP5.8 million on revenue from continuing operations of GBP20.6 million, up from GBP3.4 million. Separately, Poolbeg Pharma confirms plan to float on AIM as a spinoff of Open Orphan. Poolbeg Pharma to use IPO raise to fund clinical trial of treatment for severe influenza.

----------

Cake Box Holdings PLC, down 7.3% at 266.50p, 12-month range 155.00p-356.00p. The eggless deserts maker notes movement in shares. It confirms that it has recently emailed customers in relation to a data breach experienced in 2020 as a result of which personal and financial information may potentially have been accessed. Cake Box says it has taken the appropriate steps to investigate the incident, repair the compromised systems, and identify those customers that may have been compromised. It also has further strengthened the security of its systems to prevent future breaches, it says. "The company confirms that the data breach is not expected to have a material financial impact and as per the announcement on 12 April 2021, full year results are expected to be in line with market expectations," Cake Box adds.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Sep 2019 13:30

Midatech Pharma Secures Approval To Commence MTD201 First-Phase Study

(Alliance News) - Midatech Pharma PLC on Friday said it has received approval to start a first phase of study on MTD201, which it is developing for the treatment of acromegaly and neuroendocrine a

Read more
11 Sep 2019 12:09

Midatech Secures Spanish Government Loan To Fund MTD201 Cancer Drug

(Alliance News) - Midatech Pharma PLC's shares surged on Wednesday as said it has received a EUR6.6 million loan from the Spanish government to finance manufacturing work in its facility in in

Read more
9 Sep 2019 12:20

Midatech Pharma Appoints Former Ergomed CEO As Chief Financial Officer

(Alliance News) - Immunotherapy-focused pharmaceutical company Midatech Pharma PLC said Monday it has appointed Stephen Stamp as chief financial officer with immediate effect.He will be who

Read more
31 Jul 2019 15:54

MidaTech Pharma Appoints Frederic Duchesne As Non-Executive Director

(Alliance News) - Midatech Pharma PLC said Wednesday that Frederic Duchesne had been appointed as a non-executive director, effective immediately.Duchesne was chief executive of the of May.

Read more
19 Jul 2019 12:21

Midatech Pharma Shares Surge After Positive Diabetes Treatment Results

(Alliance News) - Shares in biopharmaceutical firm Midatech Pharma PLC surged Friday after it received positive results from its first-in-human study of its MTX102 diabetes vaccine in Midatech 13%

Read more
3 Jul 2019 12:35

Midatech Adds Two Higher Dose Levels To MTX110 Brain Tumour Drug Study

(Alliance News) - Midatech Pharma PLC on Wednesday said two higher dose levels have been added to its study of brain tumour drug MTX110 as it has been well tolerated.Shares in the oncology

Read more
13 Jun 2019 16:20

Midatech Finalises Development Plan For Acromegaly Treatment MTD201

(Alliance News) - Midatech Pharma PLC on Thursday said it has finalised the development plan for MTD201 as a treatment in patients with acromegaly and neuroendocrine tumours using its Q-Sphera in

Read more
12 Jun 2019 16:04

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18

Read more
24 Apr 2019 11:41

Midatech Pharma mired in losses as R&D costs mount

(Sharecast News) - Midatech Pharma's shares dropped on Wednesday as the company reported an annual loss and falling cash balances, though it remained confident in its ability to create value over the next 18-24 months.

Read more
24 Apr 2019 10:54

Midatech Pharma Loss Narrows As Revenue Rises Amid Refocused Business

LONDON (Alliance News) - Midatech Pharma PLC on Wednesday reported a narrowed annual loss on the back of increased revenue generation and said that the company has entered into a "new of US a

Read more
29 Mar 2019 10:40

WINNERS & LOSERS SUMMARY: TUI Hit By Grounding Of Boeing 737 Max Jet

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.5%, Glencore, up 2.6%,

Read more
29 Mar 2019 10:27

Midatech Pharma Shares Jump After Spanish Government Approves Loan

LONDON (Alliance News) - Midatech Pharma PLC on Friday said it received approval of a EUR6.6 million loan from the Spanish government for commercial scale-up of the company's cancer treatment

Read more
25 Feb 2019 15:49

Midatech Pharma Raises GBP13.4 Million In Placing And Open Offer (ALLISS)

LONDON (Alliance News) - Midatech Pharma PLC on Monday said it raised GBP13.4 million in a placing, subscription and open offer of shares at 3.85 pence each.Application has been made by the

Read more
4 Feb 2019 18:38

UPDATE: Midatech Raises GBP4.7 Million After Placing And Open Offer (ALLISS)

LONDON (Alliance News) - Midatech Pharma PLC said Monday it has raised GBP4.7 million via a share placing and open offer.Midatech said the placing and open offer was made at 3.85 pence for

Read more
4 Feb 2019 16:01

Midatech Seeks To Raise GBP4.8 Million From Placing And Open Offer (ALLISS)

LONDON (Alliance News) - Midatech Pharma PLC said Monday it intends to raise a minimum of GBP4.0 million from a share placing, plus up to GBPP750,000 from an open offer.Midatech, a research

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.